SEC Tracker
Get the app

Jasper Therapeutics JSPR

Up to 284,013,011 shares of common stock

Securities offering

Form
S-3
Filed
Importance
Routine
  1. Up to 284,013,011 shares of common stock
  2. Resale of 4,655,951 preferred shares
  3. Conversion ratio of 61 common shares per preferred share

Written from the S-3 on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Jasper Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2836 and related industry codes: the same peer list as the financial tables.

  1. Inovio Pharmaceuticals INO public float $74M, Jun 30, 2025
  2. Macrogenics MGNX public float $74M, Jun 30, 2025
  3. Volitionrx VNRX public float $73M, Jun 30, 2025
  4. XBiotech XBIT public float $77M, Jun 30, 2025
  5. Gyre Therapeutics GYRE public float $73M, Jun 30, 2025